Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 9 pages · Chinese
Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Earlier from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Postponement of Disclosure of 2025 Annual Report
- Announcement on Not Revising Downward the Conversion Price of "Shouxiangu 22 Convertible Bonds"
- Announcement on Conversion Result of ""Shouxiangu 22 Convertible Bond"" and Share Changes
- Announcement on Adding Signatory Certified Public Accountant
- Indicative Announcement on "Shouxiangu 22 Convertible Bonds" Expected to Meet Conditions for Revising Downward Conversion Price
Later from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
- Announcement on Resignation of Senior Management Member
- Announcement on Holding the 1st Investor Reception Day 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Follow-up Rating Results of "Shouxiangu 22 Convertible Bonds" in 2026
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical